| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/17/2005 | CN1655787A Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 08/17/2005 | CN1655786A Combination of a DPP IV inhibitor and a cardiovascular compound |
| 08/17/2005 | CN1655785A N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
| 08/17/2005 | CN1655784A Use of compounds that are effective as selective opiate receptor modulators |
| 08/17/2005 | CN1655783A Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
| 08/17/2005 | CN1655782A Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 08/17/2005 | CN1655781A Novel heterocyclic compounds which are active as inhibitors of beta-lactamases |
| 08/17/2005 | CN1655780A Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor |
| 08/17/2005 | CN1655779A Substituted benzazoles and methods of their use as inhibitors of Raf kinase |
| 08/17/2005 | CN1655778A Method for the use of pyranoindole derivatives to treat infection with hepatitis C virus |
| 08/17/2005 | CN1655777A A non-hormonal approach to male contraception |
| 08/17/2005 | CN1655776A Anti-constipation composition |
| 08/17/2005 | CN1655775A Use of 20-HETE synthesizing enzyme inhibitors as therapy for cerebral vascular disease |
| 08/17/2005 | CN1655774A Bis-aromatic alkanols |
| 08/17/2005 | CN1655773A Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 08/17/2005 | CN1655772A Plaster containing fentanyl |
| 08/17/2005 | CN1655771A At least partially degradable films containing an active ingredient and method for the production thereof |
| 08/17/2005 | CN1655768A Oral dosage form for controlled drug release |
| 08/17/2005 | CN1655766A Sustained release of guaifenesin combination drugs |
| 08/17/2005 | CN1655765A Sustained release pharmaceutical preparations and methods for producing the same |
| 08/17/2005 | CN1655764A Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 08/17/2005 | CN1655763A Method for preparing polymer micelle pharmaceutical preparation containing drug for injection |
| 08/17/2005 | CN1655762A Ibuprofen suspension |
| 08/17/2005 | CN1655761A Modified release pharmaceutical formulation |
| 08/17/2005 | CN1655760A Immediate release pharmaceutical formulation |
| 08/17/2005 | CN1655754A Tooth whitening products |
| 08/17/2005 | CN1655740A Condom |
| 08/17/2005 | CN1655692A Alertness bar |
| 08/17/2005 | CN1655675A Combination therapy using trefoil peptides |
| 08/17/2005 | CN1655673A Methods and compositions for treating ectoparasite infestation |
| 08/17/2005 | CN1654481A Process for preparing glucose-reducing sand sagebrush polysaccharide and its use |
| 08/17/2005 | CN1654480A Soluble highly branched glucose polymers |
| 08/17/2005 | CN1654462A Antineoplastic cocoa extracts and methods for making and using the same |
| 08/17/2005 | CN1654461A Process for preparing bis-phenyl fluorozine and its use as medicine in treatment of cardiovascular and cerebrovascular diseases |
| 08/17/2005 | CN1654074A Anti cancer gene medicinal composition, micromolecule interfere RNA and its screening method |
| 08/17/2005 | CN1654073A Paster for treating tinea unguium |
| 08/17/2005 | CN1654041A Application of eagle-tea extract total flavone in preparation of medicine for blood fat regulating |
| 08/17/2005 | CN1654040A Novel medical uses of perennial sowthistle and preparing method for intermediate thereof |
| 08/17/2005 | CN1654039A Oral formulation of hydroxycamptothecin and its preparation method |
| 08/17/2005 | CN1654038A Buccal tablet of tea polyphenol for preventing and treating colds and resisting inflammation and preparation thereof |
| 08/17/2005 | CN1654037A Dispersible tablet of tamoxifen citrate and preparation method thereof |
| 08/17/2005 | CN1215080C Substd. sapogenins and their use |
| 08/17/2005 | CN1215076C Heteroaromatic inhibitors of fructose 1, 6-bisphosphatase |
| 08/17/2005 | CN1215071C Erigeron ester B and its preparation method as well as application in pharmacy |
| 08/17/2005 | CN1215070C Use of praeruptorin C in preparing medicine for curing tumor |
| 08/17/2005 | CN1215069C Sulfonamicles and derivatives thereof that moulate the activity of endothelin |
| 08/17/2005 | CN1215067C 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
| 08/17/2005 | CN1215066C Novel indole derivatives and their use as medicaments |
| 08/17/2005 | CN1215061C Process for preparing anticancer compound, and intermediate |
| 08/17/2005 | CN1215060C Condensed pyrazole compound, composition containing it and its application |
| 08/17/2005 | CN1215059C Novel heterocyclic compounds and salts thereof and medicinal use of same |
| 08/17/2005 | CN1215055C Arylsulfonamido-substituted hydroxamic acid derivatives |
| 08/17/2005 | CN1215052C Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
| 08/17/2005 | CN1215045C Stable salts of novel derivatives of 3, 3-diphenylpropylamines |
| 08/17/2005 | CN1214818C Copolymeric micelle drug compsn. and method for the prepn. thereof |
| 08/17/2005 | CN1214815C Composition for stabilizing corneal tissue during or after orthokeratology lens wear |
| 08/17/2005 | CN1214809C Drip pills for curing aphtha and its preparing method |
| 08/17/2005 | CN1214806C Plant type composite sterilant used for mice |
| 08/17/2005 | CN1214797C Medicine for treating piles |
| 08/17/2005 | CN1214796C Method for preparing slow release micro pill of aspirin |
| 08/17/2005 | CN1214795C Use of vitamin D2 or vitamin D4 derivatives for mfg. medicament for treating secondary hyperparathyroidism |
| 08/17/2005 | CN1214794C Use of prostaglandin A1 in treatment of nerve degenerative diseases such as cerebral ischemia apoplexy |
| 08/17/2005 | CN1214793C Central nerve antalgic preparation through nasal cavity administration |
| 08/17/2005 | CN1214792C Highly absorbable solid preparation |
| 08/17/2005 | CN1214791C Quinoline keto derivatives medicinal composition and its preparing method |
| 08/17/2005 | CN1214790C Method for preparing isoxazole substituted composition for treating inflammation |
| 08/17/2005 | CN1214789C Delta 9 tetrahydrocannabinol (delta 9 THC) solution metered dose inhalers and methods of use |
| 08/17/2005 | CN1214788C Compositions for treatment and prevention of cardiovascular diseases |
| 08/17/2005 | CN1214787C Use of composition containing undecylenic acid zinc in preparation of drug of curing underarm odour |
| 08/17/2005 | CN1214786C New use of modafinil and D/L enantiomer |
| 08/17/2005 | CN1214784C Quick-releasing tablet in vagina and its preparing method |
| 08/17/2005 | CN1214783C Method for producing controlled releasing drug formulation or its precursor, the drug formulation and the precursor |
| 08/17/2005 | CN1214781C Hybrid matrices and hybrid matrix mixtures |
| 08/16/2005 | US6930207 derivatives which inhibit pancreatic lipase and therefore can be used in combating or preventing obesity and hyperlipaemias |
| 08/16/2005 | US6930188 Stable hydrate of a muscarinic receptor antagonist |
| 08/16/2005 | US6930183 a lubricant additive effective for imparting antioxidant properties to a lubricating oil, fuel composition, or rubber formulation |
| 08/16/2005 | US6930130 For use in therapy of schizophrenia, Parkinson's disease, and Alzheimer's disease |
| 08/16/2005 | US6930129 Orally administering a dosage form containing a central nervous system-acting drug in a pharmaceutically acceptable carrier, wherein said dosage release the drug at an ascending release rate for an extended time period |
| 08/16/2005 | US6930128 Estrogenic compounds as anti-mitotic agents |
| 08/16/2005 | US6930127 Veterinary treatment of ophthalmic disease in animals using topical tacrolimus |
| 08/16/2005 | US6930125 Activation of glutaminase; asthma therapy; reduction of pH |
| 08/16/2005 | US6930123 Benz(f)indole compounds useful for Inflammatory Diseases |
| 08/16/2005 | US6930122 Use of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3 -carboxamide, a salt thereof or a solvate thereof |
| 08/16/2005 | US6930121 Benzimidazole derivatives and salts and prodrugs thereof; treatment of cancers or viral infections |
| 08/16/2005 | US6930120 Oxazolyl-arylproplonic acid derivatives and their use as ppar agonists |
| 08/16/2005 | US6930119 Liquid pharmaceutical composition |
| 08/16/2005 | US6930118 3-Oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 08/16/2005 | US6930116 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals |
| 08/16/2005 | US6930115 Antitumor effect potentiators |
| 08/16/2005 | US6930114 Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors |
| 08/16/2005 | US6930113 For therapy and prophylaxis of sexual dysfunctios; hypertension, pulmonary hypertension, congestive heart failure, renal failure, myocardial infraction, stable, unstable and variant (Prinzmetal) angina, atherosclerosis |
| 08/16/2005 | US6930112 Administering antagonist for n-methylaspartic acid or gamma-aminobutyric acid |
| 08/16/2005 | US6930111 Substituted heterocyclic compounds |
| 08/16/2005 | US6930110 Nitrogen compounds such as 5-chloro-4-{4-[4-(2,3-dihydrobenzo[1,4]dioxine-5-yl)-piperazine-1-yl]-butylamino}-2H-piridazin-3-one, used as anxiolytic and hypotensive agents; side effect reduction |
| 08/16/2005 | US6930109 Antidepressant azaheterocyclyl methyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene |
| 08/16/2005 | US6930108 Nitrogen compounds such as 2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, used for prophylaxis of psoriasis, diabetes, alopecia, genetic, sexual, cardiovascular or genetic disorders |
| 08/16/2005 | US6930106 Inhibitors of HCV NS5B polymerase |
| 08/16/2005 | US6930105 Tetracyclicazaindoles and indolines having 5-HT activity |
| 08/16/2005 | US6930104 beta -amyloid precursor protein secretory stimulators; treating neurodegenerative disorders; n-carbamoyl- quinoxaline or quinoline derivatives |
| 08/16/2005 | US6930103 Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases |